Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam.

Author: ElgerChristian E, HelmstaedterChristoph, HurlemannRené, KunzWolfram S, MihovYoan, NuernbergPeter, SchochSusanne, SurgesRainer, ThieleHolger, ToliatMohammad R

Paper Details 
Original Abstract of the Article :
Levetiracetam (LEV) is a highly effective antiepileptic agent. A clinically relevant psychiatric complication of LEV treatment, however, is the provocation of irritability and aggression. Recent behavioral research indicates that personality traits may predispose to these side effects. To assess the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1528-1167.2012.03603.x

データ提供:米国国立医学図書館(NLM)

Levetiracetam: A Desert Oasis with Potential Side Effects

Levetiracetam, a widely used antiepileptic drug, is a beacon of hope for many patients with epilepsy. However, like a desert oasis that can be both refreshing and dangerous, levetiracetam can also come with potential side effects. This research investigates the genetic basis of the adverse psychotropic profile of levetiracetam, specifically focusing on the risk of irritability and aggression. The researchers conducted a candidate gene-based association study, analyzing genetic variations related to dopaminergic activity. Their findings suggest that genetic variation in dopaminergic activity may play a role in the risk for psychiatric side effects of levetiracetam.

Genetic Predisposition: Navigating the Desert of Side Effects

This research highlights the importance of considering individual genetic factors when prescribing medications. The study's findings suggest that certain genetic variations may increase the risk of psychiatric side effects from levetiracetam. This underscores the need for careful monitoring and personalized treatment approaches to minimize potential adverse events.

Navigating the Desert of Epilepsy Treatment

Epilepsy is a complex neurological condition, and this research provides valuable insights into the potential role of genetics in the development of side effects from levetiracetam. It emphasizes the importance of personalized medicine and the need for continued research to better understand the complex interplay between genetics, medications, and individual responses to treatment.

Dr.Camel's Conclusion

This research highlights the potential role of genetic variation in influencing the risk of psychiatric side effects from levetiracetam. It underscores the importance of personalized medicine and careful consideration of individual genetic factors when prescribing medications. It is a reminder that the desert of epilepsy treatment is vast and complex, requiring a multifaceted approach to ensure patient safety and well-being.

Date :
  1. Date Completed 2013-03-04
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

22881836

DOI: Digital Object Identifier

10.1111/j.1528-1167.2012.03603.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.